Equities
  • Price (USD)14.12
  • Today's Change-0.232 / -1.62%
  • Shares traded7.18k
  • 1 Year change+4.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 16:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
3407:TYO since
announced
Transaction
value
Calliditas Therapeutics ABDeal completed28 May 202428 May 2024Deal completed6.28%1.06bn
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.

Institutional shareholders

0.11%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 30 Jun 2023733.27k0.11%
RhumbLine Advisers LPas of 30 Jun 202417.18k0.00%
GAMMA Investing LLCas of 30 Sep 20244.26k0.00%
PNC Investments LLCas of 30 Sep 202417.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.